These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20037380)

  • 1. [Expression of dihydropyrimidine dehydrogenase in primary colorectal cancer and liver metastasis--a relationship between mRNA levels in cancer cells and protein levels in cancerous tissue and effect of 5-fluorouracil].
    Ishibashi K; Sobajima J; Ishiguro T; Ohsawa T; Okada N; Miyazaki T; Yokoyama M; Inokuma S; Ishida H
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2232-5. PubMed ID: 20037380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of thymidine phosphorylase in primary colorectal cancer and liver metastasis-relationship between mRNA levels in cancer cells and protein levels in cancerous tissue].
    Ishibashi K; Sobajima J; Ishiguro T; Okada N; Miyazaki T; Yokoyama M; Ishida H
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):425-9. PubMed ID: 19295266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
    Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis.
    Inokuchi M; Uetake H; Shirota Y; Yamada H; Tajima M; Sugihara K
    Cancer Chemother Pharmacol; 2004 May; 53(5):391-6. PubMed ID: 15060742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
    Kinoshita M; Kodera Y; Hibi K; Nakayama G; Inoue T; Ohashi N; Ito Y; Koike M; Fujiwara M; Nakao A
    Anticancer Res; 2007; 27(2):851-6. PubMed ID: 17465211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatic recurrence after prophylactic hepatic arterial infusion of 5-fluorouracil for Dukes' C colorectal cancer--correlation with the expression of dihydropyrimidine dehydrogenase in the primary tumor].
    Ishida H; Takeuchi I; Ohsawa T; Nakada H; Ishizuka N; Yokoyama M; Inokuma S; Suzuki T; Yamada H; Odaka A; Hoshino T; Murata N; Hashimoto D; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2267-70. PubMed ID: 12484051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of dihydropyrimidine dehydrogenase in colorectal cancer.
    Johnston SJ; Ridge SA; Cassidy J; McLeod HL
    Clin Cancer Res; 1999 Sep; 5(9):2566-70. PubMed ID: 10499634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of determinations of dihydropyrimidine dehydrogenase levels in primary and hepatic lesions of colorectal cancer patients].
    Ishida H; Hashimoto D; Inokuma S; Takeuchi I; Nakada H; Ohsawa T; Hoshino T; Murata N; Fujioka M; Idezuki Y
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1879-82. PubMed ID: 11086435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dihydropyrimidine dehydrogenase gene expression in patients with hepatic metastases from colorectal cancer].
    Shirota Y; Ichikawa W; Yamada H; Uetake H; Nihei Z; Sugihara K
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1729-31. PubMed ID: 10560382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
    Fukui Y; Oka T; Nagayama S; Danenberg PV; Danenberg KD; Fukushima M
    Int J Mol Med; 2008 Dec; 22(6):709-16. PubMed ID: 19020767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase.
    Réti A; Pap E; Adleff V; Jeney A; Kralovánszky J; Budai B
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):219-27. PubMed ID: 19830428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorouracil-related gene expression in primary sites and hepatic metastases of colorectal carcinomas.
    Sameshima S; Tomozawa S; Kojima M; Koketsu S; Motegi K; Horikoshi H; Okada T; Kon Y; Sawada T
    Anticancer Res; 2008; 28(3A):1477-81. PubMed ID: 18630501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer.
    Okumura K; Mekata E; Shiomi H; Naitoh H; Abe H; Endo Y; Kurumi Y; Tani T
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):587-94. PubMed ID: 17520254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumoral dihydropyrimidine dehydrogenase expression and efficacy of 5-fluorouracil plus leucovorin plus UFT therapy in patients with colorectal cancer].
    Ishida H; Ohsawa T; Nakada H; Yokoyama M; Inokuma S; Shirakawa K; Yamada H; Hashimoto D
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):883-7. PubMed ID: 15222105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thymidylate synthase and dihydropyrimidine dehydrogenase gene expressions in colorectal cancer using the Danenberg tumor profile method].
    Nagano H; Ichikawa W; Simizu M; Shirota Y; Nihei Z
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):889-92. PubMed ID: 15222106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between intratumoral dihydropyrimidine dehydrogenase activity and gene expression in human colorectal cancer.
    Uetake H; Ichikawa W; Takechi T; Fukushima M; Nihei Z; Sugihara K
    Clin Cancer Res; 1999 Oct; 5(10):2836-9. PubMed ID: 10537350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
    Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis.
    Kobayashi H; Sugihara K; Uetake H; Higuchi T; Yasuno M; Enomoto M; Iida S; Azuma M; Mori R; Omori A; Lenz HJ; Danenberg KD; Danenberg PV
    Int J Oncol; 2008 Dec; 33(6):1257-62. PubMed ID: 19020759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H; Iinuma H; Watanabe T
    Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.